{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:45:53Z","timestamp":1791924353635,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00719-y","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:17:55Z","timestamp":1750526275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mutational landscape of the surface antigen of hepatitis B virus in patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Arwa","family":"Bagasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Alghnnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bohol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Alhamlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Alothaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Sanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"719_CR1","doi-asserted-by":"crossref","unstructured":"Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdoli, A, Abubaker\u00a0Ali H, Adane MM, Adegboye OA, Adnani QES, Advani SM, Afzal MS, Afzal S, Aghaie\u00a0Meybodi M, Ahadinezhad B, Ahinkorah BO, Ahmad S, Ahmad T, Ahmadi S, Ahmed H, Ahmed MB, Ahmed\u00a0Rashid T, Akalu GT, Aklilu A, Akram T, Al\u00a0Hamad H, Alahdab F, Alem AZ, Alem DT, Alhalaiqa FAN, Alhassan RK, Ali L, Ali MA, Alimohamadi, Y, Alipour V, Alkhayyat M, Almustanyir S, Al-Raddadi RM, Altawalah H, Amini S, Amu H, Ancuceanu R, Andrei CL, Andrei T, Anoushiravani A, Ansar A, Anyasodor AE, Arabloo J, Arab-Zozani M, Argaw AM, Argaw ZG, Arshad M, Artamonov AA, Ashraf T, Atlaw D, Ausloos, F Ausloos M, Azadnajafabad S, Azangou-Khyavy M, Azari\u00a0Jafari A, Azarian G, Bagheri S, Bahadory S, Baig AA, Banach M, Barati N, Barrow A, Batiha A-MM, Bejarano\u00a0Ramirez DF, Belgaumi UI, Berhie AY, Bhagat DS, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bhojaraja VS, Bijani A, Biondi A, Bodicha BBA, Bojia HA, Boloor A, Bosetti C, Braithwaite D, Briko NI, Butt ZA, C\u00e1mera LA, Chakinala RC, Chakraborty PA, Charan J, Chen S, Choi J-YJ, Choudhari SG, Chowdhury FR, Chu D-T, Chung S-C, Cortesi PA, Cowie BC, Culbreth GT. Others: Global, regional, and national burden of hepatitis b, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(9), 796\u2013829.","DOI":"10.1016\/S2468-1253(22)00124-8"},{"issue":"2","key":"719_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s42770-023-00970-y","volume":"54","author":"S Boora","year":"2023","unstructured":"Boora S, Sharma V, Kaushik S, Bhupatiraju AV, Singh S, Kaushik S. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Braz J Microbiol. 2023;54(2):679\u201389.","journal-title":"Braz J Microbiol."},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-981-13-9151-4_2","volume":"1179","author":"J Wang","year":"2020","unstructured":"Wang J, Huang H, Liu Y, Chen R, Yan Y, Shi S, Xi J, Zou J, Yu G, Feng X, Lu F. HBV genome and life cycle. Adv Exp Med Biol. 2020;1179:17\u201337.","journal-title":"Adv Exp Med Biol."},{"issue":"10","key":"719_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","volume":"17","author":"PA Revill","year":"2020","unstructured":"Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. The evolution and clinical impact of hepatitis B virus genome diversity. Nature Rev Gastroenterol Hepatol. 2020;17(10):618\u201334.","journal-title":"Nature Rev Gastroenterol Hepatol."},{"issue":"6","key":"719_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/v13061124","volume":"13","author":"J Inoue","year":"2021","unstructured":"Inoue J, Sato K, Ninomiya M, Masamune A. Envelope proteins of hepatitis B virus: molecular biology and involvement in carcinogenesis. Viruses. 2021;13(6):1124.","journal-title":"Viruses"},{"issue":"14","key":"719_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3748\/wjg.v24.i14.1507","volume":"24","author":"BF Chen","year":"2018","unstructured":"Chen BF. Hepatitis B virus pre-S\/S variants in liver diseases. World J Gastroenterol. 2018;24(14):1507\u201320.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"719_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/pathogens13010046","volume":"13","author":"I Lazarevic","year":"2024","unstructured":"Lazarevic I, Banko A, Miljanovic D, Cupic M. Hepatitis B surface antigen isoforms: their clinical implications, utilisation in diagnosis, prevention and new antiviral strategies. Pathogens. 2024;13(1):46.","journal-title":"Pathogens"},{"issue":"1","key":"719_CR8","doi-asserted-by":"publisher","first-page":"16178","DOI":"10.1038\/s41598-019-52824-z","volume":"9","author":"F Pastor","year":"2019","unstructured":"Pastor F, Herrscher C, Patient R, Eymieux S, Moreau A, Burlaud-Gaillard J, Seigneuret F, Rocquigny H, Roingeard P, Hourioux C. Direct interaction between the hepatitis B virus core and envelope proteins analyzed in a cellular context. Sci Rep. 2019;9(1):16178.","journal-title":"Sci Rep."},{"key":"719_CR9","doi-asserted-by":"publisher","first-page":"00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1:00049.","journal-title":"Elife"},{"issue":"2","key":"719_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","volume":"73","author":"I Tout","year":"2020","unstructured":"Tout I, Loureiro D, Mansouri A, Soumelis V, Boyer N, Asselah T. Hepatitis B surface antigen seroclearance: immune mechanisms, clinical impact, importance for drug development. J Hepatol. 2020;73(2):409\u201322.","journal-title":"J Hepatol."},{"key":"719_CR11","unstructured":"Alper,CA. In: Pandey, J.P. (ed.) The Human Immune Response to Hepatitis B Surface Antigen, p. 0. S.Karger AG 1995."},{"issue":"3","key":"719_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/v9030056","volume":"9","author":"J Hu","year":"2017","unstructured":"Hu J, Liu K. Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses. 2017;9(3):56.","journal-title":"Viruses"},{"issue":"5","key":"719_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2217\/fvl-2019-0147","volume":"15","author":"N Warner","year":"2020","unstructured":"Warner N, Locarnini S, Xu H. The role of hepatitis B surface antibodies in HBV infection, disease and clearance. Futur Virol. 2020;15(5):293\u2013306.","journal-title":"Futur Virol"},{"issue":"3","key":"719_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0039-1685518","volume":"39","author":"E Thomas","year":"2019","unstructured":"Thomas E, Baumert TF. Hepatitis B Virus-Hepatocyte interactions and innate immune responses: experimental models and molecular mechanisms. Semin Liver Dis. 2019;39(3):301\u201314.","journal-title":"Semin Liver Dis."},{"issue":"5","key":"719_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/v15051111","volume":"15","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang Z, Ge S, Xia N, Yuan Q. Hepatitis B core antibody level: a surrogate marker for host antiviral immunity in chronic hepatitis B virus infections. Viruses. 2023;15(5):1111.","journal-title":"Viruses"},{"issue":"11","key":"719_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","volume":"18","author":"GC Fanning","year":"2019","unstructured":"Fanning GC, Zoulim F, Hou J, Bertoletti A. Therapeutic strategies for hepatitis B virus infection: towards a cure. Nat Rev Drug Discov. 2019;18(11):827\u201344.","journal-title":"Nat Rev Drug Discov."},{"issue":"4","key":"719_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/1319-3767.187609","volume":"22","author":"AA Aljumah","year":"2016","unstructured":"Aljumah AA, Abaalkhail F, Al-Ashgar H, Assiri A, Babatin M, Al Faleh F, Alghamdi A, Al-Hakeem R, Hashim A, Alqutub A, Razavi H, Sanai FM, Al-Swat K, Schmelzer J, Altraif I. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in saudi arabia in the new treatment paradigm shift. Saudi J Gastroenterol. 2016;22(4):269\u201381.","journal-title":"Saudi J Gastroenterol."},{"issue":"1","key":"719_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12879-022-07806-4","volume":"22","author":"AA Alali","year":"2022","unstructured":"Alali AA, Abo-Shehada MN. Prevalence of hepatitis B virus infection in the gulf cooperation council: a systematic review and meta-analysis. BMC Infect Dis. 2022;22(1):819.","journal-title":"BMC Infect Dis."},{"key":"719_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.104051","volume":"77","author":"AA Al-Qahtani","year":"2020","unstructured":"Al-Qahtani AA, Pourkarim MR, Trovao NS, Vergote V, Li G, Thijssen M, Abdo AA, Sanai FM, Dela Cruz D, Bohol MFF, Al-Anazi MR, Al-Ahdal MN. Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in saudi arabia: predominance of genotype D1. Infect Genet Evol. 2020;77: 104051.","journal-title":"Infect Genet Evol."},{"key":"719_CR20","doi-asserted-by":"publisher","first-page":"1260352","DOI":"10.3389\/fgene.2023.1260352","volume":"14","author":"S Qin","year":"2023","unstructured":"Qin S, Wang J, Yuan H, He J, Luan S, Deng Y. Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study. Front Genet. 2023;14:1260352.","journal-title":"Front Genet."},{"issue":"27","key":"719_CR21","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1200\/JCO.2011.36.2335","volume":"29","author":"YT Huang","year":"2011","unstructured":"Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, Iloeje UH, Chen CJ. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011;29(27):3643\u201350.","journal-title":"J Clin Oncol."},{"issue":"11","key":"719_CR22","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.hpb.2023.07.882","volume":"25","author":"U Saeed","year":"2023","unstructured":"Saeed U, Nordsletten M, Myklebust TA, Robsahm TE, Moller B, Skalhegg BS, Mala T, Yaqub S. Cancer risk and survival according to body mass index in hepatobiliary malignancies: a nationwide registry-based cohort study. HPB (Oxford). 2023;25(11):1382\u201392.","journal-title":"HPB (Oxford)"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3389\/fmicb.2020.01577","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Li Y, Yang X, Zhao J, Cheng Y, Wang J. Mechanism and complex roles of HSC70 in viral infections. Front Microbiol. 2020;11:1577.","journal-title":"Front Microbiol."},{"issue":"4","key":"719_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00430-012-0267-9","volume":"201","author":"R Prange","year":"2012","unstructured":"Prange R. Host factors involved in hepatitis B virus maturation, assembly, and egress. Med Microbiol Immunol. 2012;201(4):449\u201361.","journal-title":"Med Microbiol Immunol."},{"key":"719_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/571875","volume":"2013","author":"YM Lin","year":"2013","unstructured":"Lin YM, Jow GM, Mu SC, Chen BF. Naturally occurring hepatitis B virus b-cell and t-cell epitope mutants in hepatitis B vaccinated children. ScientificWorldJournal. 2013;2013: 571875.","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"719_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jhep.2010.10.019","volume":"55","author":"CM Bremer","year":"2011","unstructured":"Bremer CM, Sominskaya I, Skrastina D, Pumpens P, El Wahed AA, Beutling U, Frank R, Fritz HJ, Hunsmann G, Gerlich WH, Glebe D. N-terminal myristoylation-dependent masking of neutralizing epitopes in the pres1 attachment site of hepatitis B virus. J Hepatol. 2011;55(1):29\u201337.","journal-title":"J Hepatol."},{"key":"719_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.767000","volume":"12","author":"S Gu","year":"2021","unstructured":"Gu S, Liu Z, Lin L, Zhong S, Ma Y, Li X, Ye G, Wen C, Li Y, Tang L. Identification and mapping of HBsAg Loss-Related B-Cell linear epitopes in chronic HBV patients by peptide array. Front Immunol. 2021;12: 767000.","journal-title":"Front Immunol."},{"issue":"2","key":"719_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/21645515.2019.1689745","volume":"16","author":"DC Whitacre","year":"2020","unstructured":"Whitacre DC, Peters CJ, Sureau C, Nio K, Li F, Su L, Jones JE, Isogawa M, Sallberg M, Frelin L, Peterson DL, Milich DR. Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance. Hum Vaccin Immunother. 2020;16(2):251\u201368.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"719_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1006\/viro.2000.0268","volume":"270","author":"H L\u00f6ffler-Mary","year":"2000","unstructured":"L\u00f6ffler-Mary H, Dumortier J, Klentsch-Zimmer C, Prange R. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins. Virology. 2000;270(2):358\u201367.","journal-title":"Virology"},{"issue":"1","key":"719_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/viro.1998.9391","volume":"251","author":"S Jenna","year":"1998","unstructured":"Jenna S, Sureau C. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus. Virology. 1998;251(1):176\u201386.","journal-title":"Virology"},{"issue":"1","key":"719_CR31","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1080\/22221751.2022.2114849","volume":"11","author":"X Jiang","year":"2022","unstructured":"Jiang X, Chang L, Yan Y, Ji H, Sun H, Xiao Y, Song S, Feng K, Nuermaimaiti A, Wang L. Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection. Emerg Microbes Infect. 2022;11(1):2184\u201396.","journal-title":"Emerg Microbes Infect."},{"issue":"3","key":"719_CR32","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1128\/JVI.02852-13","volume":"88","author":"SA Jones","year":"2014","unstructured":"Jones SA, Clark DN, Cao F, Tavis JE, Hu J. Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming. J Virol. 2014;88(3):1564\u201372.","journal-title":"J Virol."},{"issue":"16","key":"719_CR33","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.1128\/JVI.00332-09","volume":"83","author":"S Kim","year":"2009","unstructured":"Kim S, Lee J, Ryu WS. Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation. J Virol. 2009;83(16):8032\u201340.","journal-title":"J Virol."},{"issue":"3","key":"719_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/jhep.2001.22166","volume":"33","author":"LJ Stuyver","year":"2001","unstructured":"Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology. 2001;33(3):751\u20137.","journal-title":"Hepatology"},{"issue":"3","key":"719_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0213-005X(04)73051-7","volume":"22","author":"P Leon","year":"2004","unstructured":"Leon P, Pozo F, Echevarria JM. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from spain. Enferm Infecc Microbiol Clin. 2004;22(3):133\u20137.","journal-title":"Enferm Infecc Microbiol Clin."},{"issue":"3","key":"719_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.antiviral.2012.09.014","volume":"96","author":"S Mirandola","year":"2012","unstructured":"Mirandola S, Sebastiani G, Rossi C, Velo E, Erne EM, Vario A, Tempesta D, Romualdi C, Campagnolo D, Alberti A. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy. Antiviral Res. 2012;96(3):422\u20139.","journal-title":"Antiviral Res."},{"issue":"Suppl 1","key":"719_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jmv.20608","volume":"78","author":"A Bartholomeusz","year":"2006","unstructured":"Bartholomeusz A, Locarnini S. Hepatitis B virus mutations associated with antiviral therapy. J Med Virol. 2006;78(Suppl 1):52\u20135.","journal-title":"J Med Virol."},{"issue":"1","key":"719_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/jhep.2003.50288","volume":"38","author":"CE Westland","year":"2003","unstructured":"Westland CE, Yang H, Delaney WET, Gibbs CS, Miller MD, Wulfsohn M, Fry J, Brosgart CL, Xiong S. Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B. Hepatology. 2003;38(1):96\u2013103.","journal-title":"Hepatology"},{"issue":"4","key":"719_CR39","doi-asserted-by":"publisher","first-page":"60098","DOI":"10.1371\/journal.pone.0060098","volume":"8","author":"P Chen","year":"2013","unstructured":"Chen P, Gan Y, Han N, Fang W, Li J, Zhao F, Hu K, Rayner S. Computational evolutionary analysis of the overlapped surface (s) and polymerase (p) region in hepatitis b virus indicates the spacer domain in p is crucial for survival. PLoS ONE. 2013;8(4):60098. https:\/\/doi.org\/10.1371\/journal.pone.0060098.","journal-title":"PLoS ONE"},{"issue":"31","key":"719_CR40","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1126\/sciadv.abo4184","volume":"8","author":"H Liu","year":"2022","unstructured":"Liu H, Hong X, Xi J, Menne S, Hu J, Wang JC. Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles. Sci Adv. 2022;8(31):4184.","journal-title":"Sci Adv."},{"issue":"6","key":"719_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0923-2516(91)90068-E","volume":"142","author":"P Coursaget","year":"1991","unstructured":"Coursaget P, Lesage G, Le Cann P, Mayelo V, Bourdil C. Mapping of linear b-cell epitopes of hepatitis B surface antigen. Res Virol. 1991;142(6):461\u20137.","journal-title":"Res Virol."},{"issue":"1","key":"719_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/viro.2000.0250","volume":"270","author":"CY Maeng","year":"2000","unstructured":"Maeng CY, Ryu CJ, Gripon P, Guguen-Guillouzo C, Hong HJ. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1. Virology. 2000;270(1):9\u201316.","journal-title":"Virology"},{"issue":"6","key":"719_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.virs.2023.10.007","volume":"38","author":"L Wang","year":"2023","unstructured":"Wang L, Zeng X, Wang Z, Fang L, Liu J. Recent advances in understanding T cell activation and exhaustion during HBV infection. Virologica Sinica. 2023;38(6):851\u20139.","journal-title":"Virologica Sinica."},{"issue":"2","key":"719_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5144\/0256-4947.2012.174","volume":"32","author":"AA Abdo","year":"2012","unstructured":"Abdo AA, Hassanain M, AlJumah A, Al Olayan A, Sanai FM, Alsuhaibani HA, Abdulkareem H, Abdallah K, AlMuaikeel M, Al Saghier M, Babatin M, Kabbani M, Bazarbashi S, Metrakos P, Bruix J. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med. 2012;32(2):174\u201399.","journal-title":"Ann Saudi Med."},{"issue":"2","key":"719_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jmv.23183","volume":"84","author":"Q Ma","year":"2012","unstructured":"Ma Q, Wang Y. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol. 2012;84(2):198\u2013206.","journal-title":"J Med Virol."},{"issue":"5","key":"719_CR46","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3892\/mmr.2017.6362","volume":"15","author":"H Li","year":"2017","unstructured":"Li H, Jia J, Wang M, Wang H, Gu X, Fang M, Gao C. F221Y mutation in hepatitis B virus reverse transcriptase is associated with hepatocellular carcinoma prognosis following liver resection. Mol Med Rep. 2017;15(5):3292\u2013300.","journal-title":"Mol Med Rep."},{"issue":"5","key":"719_CR47","first-page":"2689","volume":"42","author":"T Wang","year":"2018","unstructured":"Wang T, Dai Y, Zhang M, Cui D, Xu X, Sun C, Cheng J. Sequence analysis of the Pre-S gene in chronic asymptomatic HBV carriers with low-level HBsAg. Int J Mol Med. 2018;42(5):2689\u201399.","journal-title":"Int J Mol Med."},{"issue":"1","key":"719_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/molbev\/msz197","volume":"37","author":"SL Kosakovsky\u00a0Pond","year":"2019","unstructured":"Kosakovsky\u00a0Pond SL, Poon AFY, Velazquez R, Weaver S, Hepler NL, Murrell B, Shank SD, Magalis BR, Bouvier D, Nekrutenko A, Wisotsky S, Spielman SJ, Frost SDW, Muse SV. HyPhy 2.5\u2014a Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies. Mol Biol Evol. 2019;37(1):295\u20139. https:\/\/doi.org\/10.1093\/molbev\/msz197.","journal-title":"Mol Biol Evol."},{"issue":"7","key":"719_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1002764","volume":"8","author":"B Murrell","year":"2012","unstructured":"Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 2012;8(7):1\u201310. https:\/\/doi.org\/10.1371\/journal.pgen.1002764.","journal-title":"PLoS Genet."},{"issue":"5","key":"719_CR50","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/molbev\/mst030","volume":"30","author":"B Murrell","year":"2013","unstructured":"Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, Scheffler K. FUBAR: a Fast, Unconstrained Bayesian AppRoximation for Inferring Selection. Mol Biol Evol. 2013;30(5):1196\u2013205. https:\/\/doi.org\/10.1093\/molbev\/mst030.","journal-title":"Mol Biol Evol."},{"issue":"5","key":"719_CR51","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/molbev\/msi105","volume":"22","author":"SL Kosakovsky\u00a0Pond","year":"2005","unstructured":"Kosakovsky\u00a0Pond SL, Frost SDW. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22(5):1208\u201322.","journal-title":"Mol Biol Evol."},{"issue":"10","key":"719_CR52","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/s41596-022-00728-0","volume":"17","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zheng W, Li Y, Pearce R, Zhang C, Bell EW, Zhang G, Zhang Y. I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction. Nat Protoc. 2022;17(10):2326\u201353.","journal-title":"Nat Protoc."},{"issue":"11","key":"719_CR53","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1110\/ps.062405906","volume":"15","author":"P Haste Andersen","year":"2006","unstructured":"Haste Andersen P, Nielsen M, Lund O. Prediction of residues in discontinuous b-cell epitopes using protein 3D structures. Protein Sci. 2006;15(11):2558\u201367.","journal-title":"Protein Sci."},{"key":"719_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cpim.12","volume":"114","author":"S Paul","year":"2016","unstructured":"Paul S, Sidney J, Sette A, Peters B. TepiTool: a pipeline for computational prediction of T cell epitope candidates. Curr Protoc Immunol. 2016;114:18\u2013191181924.","journal-title":"Curr Protoc Immunol."},{"key":"719_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1874357901812010026","volume":"12","author":"A Petruzziello","year":"2018","unstructured":"Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J. 2018;12:26\u201332.","journal-title":"Open Virol J."},{"issue":"S1","key":"719_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(S1):4\u201313.","journal-title":"Hepatology"},{"key":"719_CR57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JHC.S307962","volume":"8","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-Induced hepatocellular carcinoma. J Hepatocell Carcinoma. 2021;8:435\u201350.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"719_CR58","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s12885-019-5916-6","volume":"19","author":"J Torresi","year":"2019","unstructured":"Torresi J, Tran BM, Christiansen D, Earnest-Silveira L, Schwab RHM, Vincan E. HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. BMC Cancer. 2019;19(1):707.","journal-title":"BMC Cancer"},{"issue":"3","key":"719_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2893.1999.00154.x","volume":"6","author":"S Zhong","year":"1999","unstructured":"Zhong S, Chan JYH, Yeo W, Tam JS, Johnson PJ. Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues. J Viral Hepatitis. 1999;6(3):195\u2013202.","journal-title":"J Viral Hepatitis"},{"issue":"1","key":"719_CR60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1):84\u2013101.","journal-title":"J Hepatol."},{"issue":"4","key":"719_CR61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1440-1746.2000.02069.x","volume":"15","author":"P Arbuthnot","year":"2000","unstructured":"Arbuthnot P, Capovilla A, Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK\/STAT pathways. J Gastroenterol Hepatol. 2000;15(4):357\u201368.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"719_CR62","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2007.09.002","volume":"133","author":"CH Chen","year":"2007","unstructured":"Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology. 2007;133(5):1466\u201374.","journal-title":"Gastroenterology"},{"issue":"11","key":"719_CR63","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1086\/592990","volume":"198","author":"CH Chen","year":"2008","unstructured":"Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. Combined mutations in pre-s\/surface and core promoter\/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis. 2008;198(11):1634\u201342.","journal-title":"J Infect Dis."},{"issue":"9","key":"719_CR64","doi-asserted-by":"publisher","first-page":"0139478","DOI":"10.1371\/journal.pone.0139478","volume":"10","author":"AY Zhang","year":"2015","unstructured":"Zhang AY, Lai CL, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF. Evolutionary changes of hepatitis B virus Pre-S mutations prior to development of hepatocellular carcinoma. PLoS ONE. 2015;10(9):0139478.","journal-title":"PLoS ONE"},{"issue":"10","key":"719_CR65","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/carcin\/bgh207","volume":"25","author":"YH Hsieh","year":"2004","unstructured":"Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25(10):2023\u201332.","journal-title":"Carcinogenesis"},{"issue":"6","key":"719_CR66","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/hep.22889","volume":"49","author":"JC Yang","year":"2009","unstructured":"Yang JC, Teng CF, Wu HC, Tsai HW, Chuang HC, Tsai TF, Hsu YH, Huang W, Wu LW, Su IJ. Enhanced expression of vascular endothelial growth factor-a in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology. 2009;49(6):1962\u201371.","journal-title":"Hepatology"},{"issue":"9","key":"719_CR67","doi-asserted-by":"publisher","first-page":"0139478","DOI":"10.1371\/journal.pone.0139478","volume":"10","author":"AY Zhang","year":"2015","unstructured":"Zhang AY, Lai CL, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF. Evolutionary changes of hepatitis B virus Pre-S mutations prior to development of hepatocellular carcinoma. PLoS ONE. 2015;10(9):0139478.","journal-title":"PLoS ONE"},{"issue":"3","key":"719_CR68","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/jmv.23200","volume":"84","author":"SR Mohebbi","year":"2012","unstructured":"Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, Derakhshan F, Sabahi F, Zali MR. Characterization of hepatitis B virus genome variability in iranian patients with chronic infection, a nationwide study. J Med Virol. 2012;84(3):414\u201323.","journal-title":"J Med Virol."},{"issue":"2","key":"719_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5114\/ceh.2019.84781","volume":"5","author":"M Taghiabadi","year":"2019","unstructured":"Taghiabadi M, Hosseini SY, Gorzin AA, Taghavi SA, Monavari SHR, Sarvari J. Comparison of pre-S1\/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic\/hepatocellular carcinoma-affected individuals. Clin Exp Hepatol. 2019;5(2):161\u20138.","journal-title":"Clin Exp Hepatol."},{"key":"719_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.615203","volume":"10","author":"Y Du","year":"2020","unstructured":"Du Y, Du B, Fang X, Shu M, Zhang Y, Chung H, Sun Y, Teng J, Visalath P, Qiu H, Cai W. ALT flare predicts hepatocellular carcinoma among antiviral treated patients with chronic hepatitis b: a Cross-Country cohort study. Front Oncol. 2020;10: 615203.","journal-title":"Front Oncol."},{"issue":"8","key":"719_CR71","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","volume":"20","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Li X, Le MH, Le AK, Yeo YH, Trinh HN, Zhang J, Li J, Wong C, Wong C, Cheung RC, Yang HI, Nguyen MH. Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase. Clin Gastroenterol Hepatol. 2022;20(8):1803\u201318125.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"719_CR72","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/135965350801300313","volume":"13","author":"RD Sloan","year":"2008","unstructured":"Sloan RD, Ijaz S, Moore PL, Harrison TJ, Teo CG, Tedder RS. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant. Antivir Ther. 2008;13(3):439\u201347.","journal-title":"Antivir Ther."},{"issue":"2","key":"719_CR73","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications. J Hepatol. 2014;61(2):408\u201317.","journal-title":"J Hepatol."},{"issue":"7","key":"719_CR74","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cmi.2015.03.004","volume":"21","author":"RK Mondal","year":"2015","unstructured":"Mondal RK, Khatun M, Ghosh S, Banerjee P, Datta S, Sarkar S, Saha B, Santra A, Banerjee S, Chowdhury A, Datta S. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in b-cell epitopes and replicative attenuation-an insight from human immunodeficiency virus\/hepatitis B virus coinfection. Clin Microbiol Infect. 2015;21(7):710\u20131120.","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"719_CR75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5001\/omj.2014.23","volume":"29","author":"FA Anvari","year":"2014","unstructured":"Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J. 2014;29(2):92\u20136.","journal-title":"Oman Med J."},{"key":"719_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699217","volume":"12","author":"X Ye","year":"2021","unstructured":"Ye X, Zhao Y, Li R, Li T, Zheng X, Xiong W, Zeng J, Xu M, Chen L. High frequency occult hepatitis B virus infection detected in Non-Resolved donations suggests the requirement of Anti-HBc test in blood donors in southern china. Front Immunol. 2021;12: 699217.","journal-title":"Front Immunol."}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00719-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T18:02:09Z","timestamp":1750528929000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00719-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00719-y","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (1975), and approved by the Institutional Review Board of King Faisal Specialist Hospital and Research Centre (project number: 2150008, date of approval 6 September 2015). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}